Chengbin Zhao - Concepedia

Author

Chengbin Zhao

Harbin Medical University

Also Known As

CHENGBIN ZHAO, Cheng-Bin Zhao, Cheng-bin Zhao, Chengbin Zhao

Publications

439

Citations

H-Index

Concepts

All Affiliations

Harbin Medical University Fourth Affiliated Hospital of Harbin Medical University First Affiliated Hospital of Zhengzhou University Zhengzhou University

About

Chengbin Zhao is an author at Harbin Medical University specializing in medicine, cell biology, and regenerative medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	230
2	Health Sciences	1	1	27
3	Natural Sciences	1	1	67
4	Social Sciences	1	1	56
5	Biochemistry	1	1	67

Chengbin Zhao

Publications

424

Citations

H-Index

Page 1

	Year	Citations
Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors Dong‐Jun Fu, Ping Li, Bowen Wu, European Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryTrimethoxyphenyl-1,2,3-triazole HybridsMolecular DiversityBiochemistry	2019	67
MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT Chengbin Zhao, Ruiming Guo, Fangxia Guan, Scientific Reports	2020	56
Dual-enzymatically cross-linked gelatin hydrogel promotes neural differentiation and neurotrophin secretion of bone marrow-derived mesenchymal stem cells for treatment of moderate traumatic brain injury Dan Zhang, Shen Guo, Chengbin Zhao, International Journal of Biological Macromolecules Tissue EngineeringTraumatic Brain InjuryNeurotrophin SecretionBiomedical EngineeringSocial Sciences	2021	56
The Neuroprotective Effect of Puerarin in Acute Spinal Cord Injury Rats Dapeng Zhang, Guozhang Ma, Mingming Hou, Cellular Physiology and Biochemistry	2016	48
Microarray expression profiles and bioinformatics analysis of mRNAs, lncRNAs, and circRNAs in the secondary temozolomide-resistant glioblastoma Chengbin Zhao, Yuyuan Gao, Ruiming Guo, Investigational New Drugs Neuro-oncologyRadiation OncologySecondary Temozolomide-resistant GlioblastomaCancer GenomicsMicroarray Expression Profiles	2019	32
Icariin attenuates titanium particle‐induced inhibition of osteogenic differentiation and matrix mineralization via miR‐21‐5p Feng Lian, Chengbin Zhao, Jing Qu, Cell Biology International	2018	28
<i>miR-30a</i> can inhibit DNA replication by targeting RPA1 thus slowing cancer cell proliferation Zhenyou Zou, Mengjie Ni, Yongfeng Chen, Biochemical Journal Cancer Cell ProliferationPathologyCell DeathCell ProliferationCancer Biology	2016	27
Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model Xiaozong Duan, Bo Yang, Chengbin Zhao, BMC Cancer	2023	23
SRCIN1 Suppressed Osteosarcoma Cell Proliferation and Invasion Peng Wang, Hu Wang, Xiaotao Li, PLoS ONE Tumor BiologySrc KinaseOncologyOncogenic AgentMedicine	2016	22
Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma Yunlong Qi, Chengbin Zhao, Hongxi Li, Tumor Biology	2016	16

Page 1